COVID 19: Diabetes and Obesity API-ICP Recommendations

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• Diabetes and obesity are significant risk factors for severe COVID-19 outcomes.
• Diabetic individuals exhibit immune defects, increasing susceptibility to infections like COVID-19.
• COVID-19 can exacerbate diabetes by causing pancreatic damage and stress hyperglycemia.

Purpose of the Study:

• To highlight the increased vulnerability of diabetic patients to COVID-19.
• To outline critical management strategies for diabetes in hospitalized COVID-19 patients.
• To emphasize the need for strict supervision for high-risk diabetic subgroups.

Main Methods:

• Review of existing literature on diabetes, obesity, and COVID-19.
• Analysis of clinical observations regarding COVID-19 impact on diabetic patients.
• Synthesis of recommendations for diabetes management during the pandemic.

Main Results:

• Diabetic patients, especially males, the elderly, and those with hypertension, heart, or kidney disease, face higher COVID-19 risks.
• COVID-19 infection can necessitate insulin therapy due to hyperglycemia and pancreatic effects.
• Effective management involves early, diabetes-specific nutrition and insulin therapy.

Conclusions:

• Diabetes and obesity significantly increase COVID-19 severity and risk.
• Prompt and specialized diabetes management, including nutrition and insulin, is crucial for hospitalized patients.
• Continuous lifestyle adherence, self-monitoring, and medication supply are vital for diabetic individuals during the pandemic.